Skip to main content
Isolator Synergy Clamps (EML2/EMR2)
Synergy Technology Customized to your Approach
This product may not be available in your specific country. Contact your local AtriCure representative to check availability.

Isolator Synergy Clamps offer superior Synergy radiofrequency (RF) technology and the choice of both right or left curved jaws and easy attach Glidepath™ tape for guided maneuverability in tight cardiac anatomy.   

  • Right and left curved jaws available
  • Synergy RF Technology
  • Easy attached Glidepath tape for guide maneuverability
Product Code(s):
EML2
EMR2

Isolator Synergy Clamps offer superior Synergy radiofrequency (RF) technology and the choice of both right or left curved jaws and easy attach Glidepath™ tape for guided maneuverability in tight cardiac anatomy.   

  • Right and left curved jaws available
  • Synergy RF Technology
  • Easy attached Glidepath tape for guide maneuverability
Product Code(s):
EML2
EMR2

Indication (Brazil, Chile, Costa Rica, EU Region, Kuwait, New Zealand, Saudi Arabia, Serbia, Taiwan, UAE, UK)

The AtriCure Bipolar (Transpolar) System is indicated for ablation and coagulation of soft tissue in general, ENT, thoracic, urological, gynecological surgical procedures and ablation of cardiac tissue during surgery including pulmonary vein isolation and atrial connecting lesions for the Maze procedure for the treatment of cardiac arrhythmias, including atrial fibrillation.

Indication (Australia, Belarus, Korea, Russia, South Africa)

The AtriCure Bipolar (Transpolar) System is intended to ablate cardiac tissue during surgery.

Indication (Argentina, Canada, Colombia, Hing Kong)

The AtriCure Bipolar (Transpolar) System is intended to ablate soft tissue during general surgical procedures.

Indication (China)

Ablation of cardiac tissue.

Indication (Japan)

This device is intended for use in ablation of cardiac tissue during surgery by use of high-frequency current.

Indication (Singapore)

The AtriCure Bipolar (Transpolar) System is indicated for ablation of cardiac tissue during surgery including pulmonary vein isolation and atrial connecting lesions for the treatment of atrial fibrillation.

PM-INTL-2675A-0525-G